Product NDC: | 54868-4277 |
Proprietary Name: | ALREX |
Non Proprietary Name: | loteprednol etabonate |
Active Ingredient(s): | 2 mg/mL & nbsp; loteprednol etabonate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SUSPENSION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-4277 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020803 |
Marketing Category: | NDA |
Start Marketing Date: | 20021017 |
Package NDC: | 54868-4277-1 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (54868-4277-1) > 5 mL in 1 BOTTLE, DROPPER |
NDC Code | 54868-4277-1 |
Proprietary Name | ALREX |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (54868-4277-1) > 5 mL in 1 BOTTLE, DROPPER |
Product NDC | 54868-4277 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | loteprednol etabonate |
Dosage Form Name | SUSPENSION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20021017 |
Marketing Category Name | NDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | LOTEPREDNOL ETABONATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |